{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:26:03Z","timestamp":1792700763818,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.surg.2015.01.006","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T01:13:21Z","timestamp":1424999601000},"page":"888-898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of\u00a0pancreatic cancer"],"prefix":"10.1016","volume":"157","author":[{"given":"Christopher J.","family":"LaRocca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Gavrikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Shanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selwyn M.","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Davydova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2015.01.006_bib1","series-title":"Cancer facts & figures\u00a02013","author":"American Cancer Society","year":"2013"},{"key":"10.1016\/j.surg.2015.01.006_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yasu.2010.05.019","article-title":"Adjuvant chemoradiation therapy for pancreas cancer: who really benefits?","volume":"44","author":"Merchant","year":"2010","journal-title":"Adv Surg"},{"key":"10.1016\/j.surg.2015.01.006_bib3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/cncr.22852","article-title":"Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database","volume":"110","author":"Bilimoria","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2015.01.006_bib4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0360-3016(87)90189-1","article-title":"Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lung","volume":"13","author":"Holsti","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.surg.2015.01.006_bib5","first-page":"5735","article-title":"Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects","volume":"50","author":"Wadler","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2015.01.006_bib6","first-page":"29","article-title":"The promise of biochemical modulation in combined modality therapy","volume":"21","author":"Vokes","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1016\/j.surg.2015.01.006_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1124\/mol.53.2.252","article-title":"Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma","volume":"53","author":"Ismail","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.surg.2015.01.006_bib8","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.ejca.2011.03.009","article-title":"Type I interferons as radiosensitisers for pancreatic cancer","volume":"47","author":"Morak","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surg.2015.01.006_bib9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3748\/wjg.v11.i10.1521","article-title":"Synergistic effects of interferon-alpha in combination with chemoradiation on human pancreatic adenocarcinoma","volume":"11","author":"Ma","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2015.01.006_bib10","first-page":"1499","article-title":"Interferon-alpha restitutes the chemosensitivity in pancreatic cancer","volume":"28","author":"Hoffmann","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.surg.2015.01.006_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ctrv.2013.05.008","article-title":"Adjuvant therapy for resectable pancreatic adenocarcinoma: review of the current treatment approaches and future directions","volume":"40","author":"Antoniou","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.surg.2015.01.006_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0002-9610(00)00369-X","article-title":"Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma","volume":"179","author":"Nukui","year":"2000","journal-title":"Am J Surg"},{"key":"10.1016\/j.surg.2015.01.006_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9610(03)00051-5","article-title":"Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma","volume":"185","author":"Picozzi","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.surg.2015.01.006_bib14","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1200\/JCO.2011.38.2960","article-title":"Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma","volume":"30","author":"Schmidt","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2015.01.006_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjc.6602713","article-title":"Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer","volume":"93","author":"Ohashi","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surg.2015.01.006_bib16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/sj.mt.6300064","article-title":"Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus","volume":"15","author":"Shashkova","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.surg.2015.01.006_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.cgt.7701107","article-title":"Anticancer activity of oncolytic adenovirus vector armed with IFN-alpha and ADP is enhanced by pharmacologically controlled expression of TRAIL","volume":"15","author":"Shashkova","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.surg.2015.01.006_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1349-7006.2007.00408.x","article-title":"Local interferon-alpha gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster","volume":"98","author":"Hara","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.surg.2015.01.006_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ymthe.2004.05.027","article-title":"Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein","volume":"10","author":"Benedict","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.surg.2015.01.006_bib20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/jgm.602","article-title":"Interferon-alpha and antisense K-ras RNA combination gene therapy against pancreatic cancer","volume":"6","author":"Hatanaka","year":"2004","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.surg.2015.01.006_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.amjsurg.2012.02.016","article-title":"Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy","volume":"204","author":"Armstrong","year":"2012","journal-title":"Am J Surg"},{"key":"10.1016\/j.surg.2015.01.006_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.surg.2012.02.017","article-title":"Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy","volume":"152","author":"Armstrong","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2015.01.006_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1099\/0022-1317-40-1-45","article-title":"Infection of mouse liver by human adenovirus type 5","volume":"40","author":"Duncan","year":"1978","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.surg.2015.01.006_bib24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1073\/pnas.88.5.1651","article-title":"A\u00a0mouse model for investigating the molecular pathogenesis of adenovirus pneumonia","volume":"88","author":"Ginsberg","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.surg.2015.01.006_bib25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-05-3497","article-title":"Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors","volume":"66","author":"Thomas","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2015.01.006_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-12-398342-8.00003-3","article-title":"Chapter three\u2013Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds","volume":"115","author":"Wold","year":"2012","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.surg.2015.01.006_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1349-7006.2000.tb01005.x","article-title":"Effect of angiostatin on liver metastasis of pancreatic cancer in hamsters","volume":"91","author":"Yanagi","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.surg.2015.01.006_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1349-7006.2009.01407.x","article-title":"In\u00a0vivo bioimaging tracks conditionally replicative adenoviral replication and provides an early indication of viral antitumor efficacy","volume":"101","author":"Davydova","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.surg.2015.01.006_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/viro.2002.1772","article-title":"Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus","volume":"305","author":"Doronin","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.surg.2015.01.006_bib30","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/JVI.74.13.6147-6155.2000","article-title":"Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein","volume":"74","author":"Doronin","year":"2000","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.surg.2015.01.006_bib31","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1158\/0008-5472.CAN-04-0064","article-title":"Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment","volume":"64","author":"Davydova","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2015.01.006_bib32","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0016-5085(03)01196-X","article-title":"Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer","volume":"125","author":"Yamamoto","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2015.01.006_bib33","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1158\/0008-5472.CAN-05-1871","article-title":"Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region","volume":"65","author":"Ono","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2015.01.006_bib34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.gt.3301473","article-title":"Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors","volume":"8","author":"Wesseling","year":"2001","journal-title":"Gene Ther"},{"key":"10.1016\/j.surg.2015.01.006_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.molmed.2012.04.008","article-title":"Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond","volume":"18","author":"Kaufmann","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.surg.2015.01.006_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mt.2009.266","article-title":"Current issues and future directions of oncolytic adenoviruses","volume":"18","author":"Yamamoto","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.surg.2015.01.006_bib37","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1128\/JVI.00205-12","article-title":"A\u00a0new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses","volume":"86","author":"Wang","year":"2012","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.surg.2015.01.006_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.surg.2015.01.006_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjsurg.2007.04.014","article-title":"Optimization of conditionally replicative adenovirus for pancreatic cancer and its evaluation in an orthotopic murine xenograft model","volume":"195","author":"Ramirez","year":"2008","journal-title":"Am J Surg"},{"key":"10.1016\/j.surg.2015.01.006_bib40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ijc.28395","article-title":"Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis","volume":"134","author":"Ottolino-Perry","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.surg.2015.01.006_bib41","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/sj.cgt.7700403","article-title":"Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma","volume":"8","author":"Wesseling","year":"2001","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.surg.2015.01.006_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1593\/neo.04700","article-title":"Cyclooxygenase-2 expression in hamster and human pancreatic neoplasia","volume":"8","author":"Crowell","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.surg.2015.01.006_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/mthe.2001.0275","article-title":"Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers","volume":"3","author":"Yamamoto","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.surg.2015.01.006_bib44","first-page":"S11","article-title":"Biologic response modifiers: the interferon alfa experience","volume":"46","author":"Koeller","year":"1989","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.surg.2015.01.006_bib45","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.gt.3301949","article-title":"Adenovirus-mediated gene transfer of interferon alpha improves dimethylnitrosamine-induced liver cirrhosis in rat model","volume":"10","author":"Suzuki","year":"2003","journal-title":"Gene Ther"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606015000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606015000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:50:37Z","timestamp":1758538237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606015000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0039606015000185"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2015.01.006","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of\u00a0pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2015.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}